Case Study: Celerion achieves paperless, faster Phase I consenting and improved participant experience with Veeva Systems' eConsent

Enhance Patient-Centricity and Improve Efficiency with Veeva eConsent

Celerion, a Phase I clinical research company, needed a faster, more reliable way to consent and manage large volumes of participants. Paper-based processes created storage and legibility problems, long onsite monitoring times, and high call-center volumes, and previous eConsent tools couldn’t keep up with the speed and scale required for Phase I studies.

Celerion adopted Veeva eConsent and the MyVeeva for Patients app, using easy-to-update consent templates and real-time access to documents. The change eliminated massive printing, reduced monitor onsite time and call-center inquiries, improved participant satisfaction, and delivered measurable gains: 5,378 participants, 17,815 eConsents signed, and roughly 801,480 pages of paper saved.

Celerion

Staci McDonald

Executive Director, Scientific Clinical Operations